syngen bone marrow transplant immunotherapi murin b-cell lymphoma activ immun tumor-deriv idiotyp immunoglobulin recurr underli malign major caus treatment failur autolog bone marrow transplant bmt patient lymphoma regard immunotherapeut approach resist residu tumor cell bmt previou studi model system lethal b-cell lymphoma origin activ immun purifi tumor-deriv surfac immunoglobulin Id tumor-associ antigen resist growth Id immun mice week reconstitut syngen bone marrow surviv tumor challeng control low level idiotype-specif antibodi sera immun mice earli time function studi literatur immunocompet syngen reconstitut incomplet recoveri immun mice lethal irradi syngen marrow reconstitut signific resist challeng persist host antitumor immun total bodi irradi studi feasibl id immun conjunct bone marrow transplant 